Basics Soleno Therapeutics, Inc. Common Stock Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. IPO Date: November 10, 2014 Sector: Healthcare Industry: Biotech Market Cap: $2.76B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 3.64% Avg Daily Range (30 D): $1.67 | 3.22% Avg Daily Range (90 D): $1.91 | 3.10% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): 1.87M Avg Daily Volume (90 D): 1.71M Trade Size Avg Trade Size (Sh.): 136 Avg Trade Size (Sh.) (30 D): 67 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 2,093 Avg Inst. Trade: $2.79M Avg Inst. Trade (30 D): $2.66M Avg Inst. Trade (90 D): $3.1M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.48M Avg Closing Trade (30 D): $7.07M Avg Closing Trade (90 D): $9.65M Avg Closing Volume: 95.66K     News Dec 4, 2025 @ 12:02 AM Soleno Turns First Profit on $66 Million in Revenu... Source: Jonathan Ponciano Dec 1, 2025 @ 10:48 PM Johnson Fistel Begins Investigation on Behalf of S... Source: Johnson Fistel, Pllp Oct 28, 2025 @ 12:00 PM Soleno Therapeutics to Participate in Upcoming Nov... Source: Brian Ritchie, Lifesci Advisors, Llc Oct 28, 2025 @ 1:41 AM SLNO Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm Oct 22, 2025 @ 12:00 PM Cassava Sciences Appoints Dawn C. Bir to the Board... Source: Cassava Sciences, Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.81 $.49 $-.09 Diluted EPS $-1.83 $.47 $-.09 Revenue $ 98.68M $ 66.02M $ 32.66M Gross Profit $ $ 64.88M $ 31.96M Net Income / Loss $ -78.45M $ 26.01M $ -4.71M Operating Income / Loss $ -89.28M $ 22.11M $ -6.53M Cost of Revenue $ $ 1.14M $ .7M Net Cash Flow $ 198.25M $ 170.17M $ -4.83M PE Ratio     Splits Aug 26, 2022:   1:15 Oct 06, 2017:   1:5